science π¬ New drug targets malaria parasite in liver
Australian scientists have developed a novel anti-malarial drug targeting the Plasmodium parasite's transition from liver cells to the bloodstream. This breakthrough comes from researchers at Melbourne's Walter and Eliza Hall Institute. The drug kills the parasite at a crucial late liver stage, which surprisingly elicits a powerful immune response. This immune boost could offer long-lasting protection, even against future malaria variants. The current evidence supporting this concept is based on preclinical models using different strains of mice. π¬